| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/28/2011 | EP2367814A1 New compounds 578 |
| 09/28/2011 | EP2367798A2 Treatment of amyotrophic lateral sclerosis |
| 09/28/2011 | EP2367788A1 3-phenyl-3-methoxypyrrolidine derivatives as modulators of cortical catecholaminergic neurotransmission |
| 09/28/2011 | EP2367787A1 3-phenyl-3-methoxypyrrolidine derivatives as modulators of cortical catecholaminergic neurotransmission |
| 09/28/2011 | EP2367786A1 Novel 1 -alkyl- 3 -hydroxy- 3 -phenylazetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission |
| 09/28/2011 | EP2367785A1 Novel 3-phenyl-azetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission |
| 09/28/2011 | EP2367599A1 Inhibition of hdac2 to promote memory |
| 09/28/2011 | EP2367548A1 Medical dietary composition for treating neurodegenerative diseases |
| 09/28/2011 | EP2367547A1 L-lysine for improving normal cognitive functions |
| 09/28/2011 | EP2367545A1 Di-vanilloyl and tri-vanilloyl derivatives for use in anti-cancer therapy |
| 09/28/2011 | EP2367544A2 Method of treatment of aggression |
| 09/28/2011 | EP2367543A2 5-ht2a and 5-ht2b receptor antagonist for treating stenosis of the spinal canal |
| 09/28/2011 | EP2367449A1 Composition comprising isoflavones |
| 09/28/2011 | EP2244703B1 Pharmaceuticals and the production and use thereof in the treatment of painful neuropathies |
| 09/28/2011 | EP2133335B1 Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor |
| 09/28/2011 | EP2103305B1 Therapeutic agent for diabetic neuropathy |
| 09/28/2011 | EP2041131B1 Azaindole derivatives with a combination of partial nicotinic acetylcholine receptor agonism and dopamine reuptake inhibition |
| 09/28/2011 | EP1937827B1 Antibodies and their use in the treatment, prevention and diagnosis of a disease associated with sod1 abnormalities |
| 09/28/2011 | EP1864131B1 Natural ligand of g protein coupled receptor rcc356 and uses thereof |
| 09/28/2011 | EP1861363B1 Method of preparation of pure 4-pyrrolidinophenylbenzyl ether derivatives as maob inhibitors |
| 09/28/2011 | EP1424330B1 Activator for peroxisome proliferator-responsive receptor delta |
| 09/28/2011 | EP1421191B1 Humanised antibodies specific for both CD45RB and CD45RO |
| 09/28/2011 | EP1420800B1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at 4) receptor activity |
| 09/28/2011 | EP1355669B1 Augmented cognitive training |
| 09/28/2011 | EP1353684B8 Use of inhibitors of dipeptidypeptidase iv (ec 3.3.14.5) and aminopeptidase n (ec 3.4.11.2) for the treatment of neurodegeneration induced by ischaemia |
| 09/28/2011 | EP1237891B1 Heterocyclic dihydropyrimidines as potassium channel inhibitors |
| 09/28/2011 | CN1961877B Pharmaceutical composition for treating withdrawal syndrome |
| 09/28/2011 | CN1915981B 2-oxy-benzoxazinone derivatives for the treatment of obesity |
| 09/28/2011 | CN1732259B Method of degrading hardly degradable protein |
| 09/28/2011 | CN1646139B Use of pyrimidine nucleotides for the treatment of affections of the peripheral nervous system |
| 09/28/2011 | CN102203130A Glp-1 derivative and application thereof |
| 09/28/2011 | CN102203096A Compounds that expand hematopoietic stem cells |
| 09/28/2011 | CN102203093A Aminotriazolopyridines and their use as kinase inhibitors |
| 09/28/2011 | CN102203089A N-sulfonamido polycyclic pyrazolyl compounds |
| 09/28/2011 | CN102203077A ( pyrrolidin-2 -yl) phenyl derivatives for use in the treatment of pain |
| 09/28/2011 | CN102203068A Cyclohexane derivative and pharmaceutical use thereof |
| 09/28/2011 | CN102202680A Use of stem cells to prevent neuronal dieback |
| 09/28/2011 | CN102202666A Therapeutic uses of compounds having affinity to the serotonin transporter, serotonin receptors and noradrenalin transporter |
| 09/28/2011 | CN102202662A Agent for treatment of diabetes |
| 09/28/2011 | CN102202660A Pharmaceutical combination comprising 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3 diol and paracetamol |
| 09/28/2011 | CN102202519A Method for producing lipid |
| 09/28/2011 | CN102199656A Method and reagent for regulating and controlling development and transformation of bone marrow |
| 09/28/2011 | CN102199627A Constructing method of bicistronic recombinant adenovirus expressing neurotrophic factor and tyrosine hydroxylase |
| 09/28/2011 | CN102199587A Functional mutant of human plasminogen, its preparation method and application |
| 09/28/2011 | CN102199515A Health-care wine and preparation method thereof |
| 09/28/2011 | CN102199155A Method for preparing humantenmine from elegant Jessamine extracts |
| 09/28/2011 | CN102199150A Optical active oxazolidinone derivatives as well as preparation methods and application to preparing medicaments |
| 09/28/2011 | CN102199144A Benzimidazole derivatives |
| 09/28/2011 | CN102199134A Thiadiazole histone deacetylase inhibitors and application thereof |
| 09/28/2011 | CN102199123A New crystal form and pharmaceutical application of fasudil |
| 09/28/2011 | CN102199081A 2-acetylaloeemodin and preparation method and application thereof |
| 09/28/2011 | CN102198272A Medicinal composition for promoting fracture union and repairing injured nerves |
| 09/28/2011 | CN102198256A Method for preparing warm-pungent and exterior syndrome relieving essential oil clathrate compound and application of essential oil clathrate compound in accessories |
| 09/28/2011 | CN102198253A Traditional Chinese medicine composition for resisting depression, and preparation method as well as application thereof |
| 09/28/2011 | CN102198248A Traditional Chinese medicine for treating nervous headache |
| 09/28/2011 | CN102198241A Medicine for alleviating nervousness and taking care of sub-health |
| 09/28/2011 | CN102198240A Medicament for treating headache |
| 09/28/2011 | CN102198220A Medicine for fatigue resistance and memory enhancement |
| 09/28/2011 | CN102198211A Traditional Chinese medicine composition for treating neurasthenia, and preparation method thereof |
| 09/28/2011 | CN102198201A Traditional Chinese medicine composition for treating deficiency-cold headache |
| 09/28/2011 | CN102198199A Plaster for treating facial nerve paralysis and preparation method thereof |
| 09/28/2011 | CN102198188A Externally-applied Chinese medicinal tincture for treating neurodynia and toothache |
| 09/28/2011 | CN102198187A Traditional Chinese medicine for treating epilepsy |
| 09/28/2011 | CN102198179A Medicament for relieving alcoholism |
| 09/28/2011 | CN102198178A Zhenrong Yinao capsules |
| 09/28/2011 | CN102198171A Traditional Chinese medicine preparation for mainly treating angina, prosopalgia and headache, and preparation method thereof |
| 09/28/2011 | CN102198160A Medicine composition for treating headache or insomnia as well as preparation method and purpose thereof |
| 09/28/2011 | CN102198143A Application of harpagoside in pharmacy |
| 09/28/2011 | CN102198127A Application of gambogic acid in preparing inflammation inhibitor |
| 09/28/2011 | CN102198113A Preparation process of quetiapine fumarate slow release tablet |
| 09/28/2011 | CN102197936A Method for preparing pine needle health-care pillow |
| 09/28/2011 | CN101961363B Preparation method of active pseudo-ginseng slices |
| 09/28/2011 | CN101940750B Traditional Chinese medicine for senile dementia and preparation method thereof |
| 09/28/2011 | CN101891738B Dasatinib polymorph and preparation method and medical composition thereof |
| 09/28/2011 | CN101843587B Method for preparing ornithine aspartate powder injection for injection |
| 09/28/2011 | CN101766767B Chinese medicine composition for headaches |
| 09/28/2011 | CN101745118B Cell cytokine for treatment of Alzheimer |
| 09/28/2011 | CN101716288B Traditional Chinese medicine preparation for treating postconcussion syndrome |
| 09/28/2011 | CN101693113B Divalproex sodium medicine composition with improved oral absorptivity |
| 09/28/2011 | CN101653470B Sensitive plant total alkaloid extract and preparing method and application thereof |
| 09/28/2011 | CN101647944B Use of novel Xianlinggubao preparation |
| 09/28/2011 | CN101607951B Method for preparing escitalopram |
| 09/28/2011 | CN101570528B Glycyrrhizin derivatives and preparation and use thereof |
| 09/28/2011 | CN101564494B Use of traditional Chinese composition |
| 09/28/2011 | CN101563075B Therapeutic agent for diabetic neuropathy |
| 09/28/2011 | CN101544644B Preparation method of mianserin hydrochloride |
| 09/28/2011 | CN101543522B Facial palsy healing paste |
| 09/28/2011 | CN101491516B Use of tanshinone compound in preparing analgesic |
| 09/28/2011 | CN101485814B Supercritical CO2 extraction method for saponin component in Paris polyphylla var. yunnanensis |
| 09/28/2011 | CN101401827B Pharmaceutical use of paecilomyces Gunnii mycelium crude polysaccharides extract |
| 09/28/2011 | CN101390941B Use of medicine composition in preparing medicine for treating insomnia |
| 09/28/2011 | CN101346372B Aryl-isoxazolo-4-yl-oxadiazole derivatives |
| 09/28/2011 | CN101318020B Anti-anxiety or/and dumps medicament composition and uses thereof |
| 09/28/2011 | CN101311171B Compound with dual restraining activities to acetyl cholinesterase and butyryl cholinesterase and use thereof |
| 09/28/2011 | CN101277952B Isoxazole derivatives |
| 09/28/2011 | CN101181425B Chinese medicine externally used liniment |
| 09/28/2011 | CN101087760B Crystalline aripiprazole solvates |
| 09/27/2011 | US8026273 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient |
| 09/27/2011 | US8026272 Modified lysine-mimetic compounds |
| 09/27/2011 | US8026268 Method for scavenging radicals with urocanic acid, derivatives and analogues |